PureTech Announces Annual Results for Year Ended December 31, 2020
By
Staff
2 seconds ago
Strong capital base and cash runway extended into the first quarter of 2025, with PureTech level cash and cash equivalents of $443.4 million as of March 31, 2021
1 ($349.4 million as of December 31, 2020
2) and consolidated cash and cash equivalents of $486.5 million as of March 31, 2021
3 ($403.9 million as of December 31, 2020
4)
Advancement of Wholly Owned Pipeline with four clinical trial initiations and one successful readout, with three clinical trials ongoing
Significant milestones across PureTech’s Founded Entities including one FDA Clearance for Marketing, two European Marketing Authorizations, initiation of a Phase 3 program, $247.8 million raised in 2020
5 and $473.2 million raised in the 2021 post-period
Health Care Leadership During COVID-19 harvard.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from harvard.edu Daily Mail and Mail on Sunday newspapers.
Lutronic Announces Strong Year in 2020 & Appoints Dr. Omar Ibrahimi of Connecticut as its Medical Director
Share Article
Lutronic Aesthetics (Billerica, MA) Announces a Strong 2020 Performance Aided by The Introduction of Lutronic Hollywood Spectra™ and Dr. Omar Ibrahimi, MD, Ph.D. of Connecticut is Appointed Medical Director
“This partnership with a very distinguished and widely peer respected physician such as Dr. Ibrahimi provides Lutronic with an advantage for its continued efforts in R&D and clinical development,” says Larry Laber, Chief Commercial Officer.” BILLERICA, Mass. (PRWEB) March 08, 2021 Lutronic, a leading developer of energy-based medical devices, announces a strong 2020 U.S. performance. The Company has had a double-digit growth year-over-year despite the challenge of the world-wide COVID-19 pandemic. Lutronic’s success was supported by implementing a company-wide COVID-19 safety pro